期刊文献+

检测C-反应蛋白在冠心病病变程度及预后价值的探讨

A discussion of the severity and prognosis inthe relationship between c-reactive protein and coronary heart disease of tested
下载PDF
导出
摘要 目的 :探讨C -反应蛋白 (CRP)与冠心病 (CHD)病变程度及预后之间的关系。方法 :测定经临床确诊的CHD患者 1 38例的血清CRP浓度 ,并与非冠心病患者 5 9例的血清CRP浓度相比较。结果 :急性心肌梗死 (AMI)、不稳定型心绞痛 (UA)、稳定型心绞痛 (SA)及对照组其CRP血清浓度分别为 1 3.2 6± 1 .6 7mg/L、1 1 .2 3± 1 .0 8mg/L、8.1 7± 2 .0 1mg/L、4 .6 2± 1 .6 8mg/L、其中CHD单支变、双支病变及三支病变者其CRP浓度依次增高 ,分别为 8.5 4± 2 .0 3mg/L、1 0 .2 8± 1 .95mg/L、1 2 .1 9± 2 .37mg/L ,显示随着CRP浓度增高病变程度加重、发生急性冠状动脉事件也增高。结论 :检测血清CRP浓度对了解冠心病病变程度及预后有重要价值 。 Objective: A Disussion of the seveity and prognosis inthe reletionship between C-reactive protein(CRP) and coronary heart disease (CHD) .Methods: The plasma CRP concentrations were tested in 138 cases CHD and normal control group 59 cases .Results: Acute myocardia infarction (AMI), unstable angina pectoris (UA) ,stable angina pectoris(SA) and normal control group ,the plasma CRP concentrations was 13.26±1.67, 11.23±1.08, 8.17±2.01, 4.62±1.68 mg/L, respectively in the CHD group, the plasma concentrations were,8.54±2.03 ,10.28±1.95, 12.19±2.37 mg/L, respectively,for the 1-vessel-disease ,the 2-vessel-disease and the 3-disease,the indices of CRP concentrations higher was closely associated with pathological changes and acute coronary incident. Conclusion: The plasma CRP concentrations of tested to coronary heart disease of pathological changes severity and prognosis has important significance , one index for coronary heart diseases of detection.
作者 黄荣宁 李平
出处 《河北医学》 CAS 2003年第10期893-895,共3页 Hebei Medicine
关键词 C-反应蛋白 冠心病病变程度 预后 C-reactive protein Coronary heart disease pathological changes severity Prognlsis
  • 相关文献

参考文献9

  • 1杨胜利,何秉贤.C-反应蛋白与冠心病[J].中华心血管病杂志,2001,29(3):187-188. 被引量:445
  • 2Berk B C. Elevation of C- reactive protein in acute cononary anery disease[J].Am J Cardial, 1990,65:168.
  • 3Liuzzo G . The prognostic value of C - reactive proteLn and serum amyloid A protein in severe unstable angina[J].N Engt J med,1994,331:417.
  • 4Ross R. Atherosclerosis An irflam matory disease[J] .N Engl J Med, 1999,340:115 - 126.
  • 5Anderson J L, Carlquist J F, Joseph B, et al Evaluation of C -reactive protein, an inflammatory market, and infectious serology as risk factor for coronary artery disease and myocardial infarction[J]. JACC, 1998,32: 35.
  • 6Haverkate F, Thompson S G, Puke S D M, et al. production M C- reactive protein and risk M coronary events in stable and unstable angina: Europear concerted action on thrombosis and disabilities angina pectoris study group[J] .lancet, 1997,349:462.
  • 7Mehta JL,Saldeen TG,Rand K Interaction role of infection, inflammation and traditional risk factors in athetosclerosis and coronary artery disease[J] .J Am collcardiol,1998,31 : 1217.
  • 8Jerffery L, Anderson MD, FACC JF, et al Evaluation of C - reactive protein, an inflammatory market and infectious serology as risk factors for coronary disease and myocardial infaction[J]. J Am coll cardiol, 1998,32:35.
  • 9Tatarn M C, Heinrich J, Juuker R, et al . C- reactive protein and the severity of atherosdercs is in myocanlial infarction patients with stable angina pectoris [ J]. Eur heart J, 2000, 21:1000.

二级参考文献3

  • 1US Departmentof Healthand Human Services Monograph,1996年,30页
  • 2Hatanaka K,Pathol Int,1995年,45卷,631页
  • 3Liuzzo G,New Engl J Med,1994年,331卷,417页

共引文献444

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部